Document is current
Any future updates will be listed below
-
Authors
Wittel, U. A. https://orcid.org/0000-0001-6194-2374
Lubgan, D.
Ghadimi, M.
Belyaev, O.
Uhl, W.
Bechstein, W. O.
Grützmann, R.
Hohenberger, W. M.
Schmid, A.
Jacobasch, L.
Croner, R. S.
Reinacher-Schick, A.
Hopt, U. T.
Pirkl, A.
Oettle, H.
Fietkau, R.
Golcher, H.
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (109284)
- License Information
-
More Information
Article History
Received: 22 October 2018
Accepted: 10 September 2019
First Online: 22 October 2019
Ethics approval and consent to participate
: Patients were included after written informed consent was obtained. The trial was conducted following ICH-GCP guidelines, approved by the Ethics Committee of the University Hospital Erlangen (322_12AZ) and by the Federal Institute for Drugs and Medical Devices (BfArM 4038763). The trial registration (EudraCT: 2009–014476-21, NCT01827553) was obtained prior to recruitment.
: NA.
: The authors declare that they have no competing interests.
